Skip to main content
editorial
. 2023 Jul 26;24(15):11990. doi: 10.3390/ijms241511990
ACTB Actin Beta
AE Adverse effect
AKT1 RAC-alpha serine/threonine-protein kinase
ATRA All-trans retinoic acid
BC Breast cancer
BCC Breast cancer cells
CTC Circulating tumor cells
COL4A5 Collagen type IV alpha 5 chain
CTNNA1 Catenin alpha 1
CTNNB1 Catenin beta 1
D Day
ECM Extracellular matrix
EGFR Epidermal growth factor receptor
ERα Estrogen receptor-alpha
ERβ1 Estrogen receptor-beta1
ERK1 Extracellular signal-regulated kinase 1
EVs Extracellular vesicles
FAs Fibroadenomas
FELs Fibro-epithelial lesions
GRHL2 Grainyhead-like 2
Her-2 Human epidermal growth factor receptor 2
ITGB1 Integrin-beta1
MAPK14 Mitogen-activated protein kinase 14; p38
MCSs Multicellular spheroids
NACT Neoadjuvant chemotherapy
OHT 4-hydroxytamoxifen
OS Overall survival
PD Progression of disease
PTs Phyllodes tumors
PD-L1 Programmed cell death ligand-1
RPM Random positioning machine
sTILs Stromal tumor-infiltrating lymphocytes
TNBC Triple-negative breast cancer
TUBB Tubulin-beta